Teva, Granules, Heritage $5.55M Metformin Settlements
Who Is Eligible?
You may be eligible to file a claim if you:
- Purchased Metformin products manufactured by Teva Pharmaceuticals
- Purchased Metformin products manufactured by Granules USA
- Purchased Metformin products manufactured or distributed by Heritage Pharmaceuticals
- Used prescription Metformin during the relevant time periods
- Have documentation of your Metformin purchases or prescriptions
How Much Can You Get?
The three companies have agreed to pay a combined total of $5.55 million to settle the class action lawsuits. The exact amount each eligible claimant will receive depends on factors such as the number of valid claims filed and the specific products purchased. Payment amounts will be determined based on your documented purchases and usage of the affected Metformin products. Details about the specific payout structure are still being finalized.How to File Your Claim
Filing your claim is quick and easy:
- Gather documentation of your Metformin purchases, including receipts, pharmacy records, or prescription information
- Review the settlement details to confirm your eligibility
- Complete the required claim form with accurate information about your purchases
- Submit any required proof of purchase or prescription records
- Download the Class Action Buddy app to easily track your claim status and get help filing
💡 Easier way: File with Class Action Buddy
Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.
Download for iPhone Download for AndroidFrequently Asked Questions
What is the deadline to file a claim for the Teva, Granules, Heritage $5.55M Metformin Settlements?
The current deadline to file a claim is Jul 10, 2026. Note: claims sent by mail must be postmarked by this date, and Class Action Buddy ships claim forms with a 7-day mailing buffer to ensure on-time delivery.
How much can I receive from the Teva, Granules, Heritage $5.55M Metformin Settlements?
The maximum payout per eligible claimant is up to Pro rata share of $5.55M fund. Actual payments may be lower depending on the total number of valid claims filed and the available settlement fund.
Do I need proof of purchase for the Teva, Granules, Heritage $5.55M Metformin Settlements?
Yes — this settlement requires proof of purchase. Acceptable proof typically includes receipts, credit card statements, photos of the product, or order confirmation emails. Check the official claim form for specifics.
How do I file a claim for the Teva, Granules, Heritage $5.55M Metformin Settlements?
You have two options: (1) Use the free Class Action Buddy mobile app — set up your profile once and the app auto-fills the PDF claim form, captures your signature, and submits the claim by mail on your behalf. (2) File directly with the settlement administrator using the official claim form linked on this page.
What Metformin products are covered in this settlement?
The settlements cover Metformin products that were manufactured or distributed by Teva Pharmaceuticals, Granules USA, and Heritage Pharmaceuticals. Specific product details and time periods will be outlined in the final settlement agreements.
How much money can I get from the Metformin settlement?
The total settlement amount is $5.55 million across all three companies. Individual payouts will depend on the number of valid claims filed and your documented purchases of the affected products.
Do I need receipts to file a Metformin settlement claim?
While specific proof requirements are still being determined, having documentation such as receipts, pharmacy records, or prescription information will likely strengthen your claim and may be required for compensation.
Ready to File Your Claim?
We're adding new settlements regularly. Download the app to get notified when this one is available.
Download Class Action Buddy →Get Notified About New Settlements
We find new class action settlements every week. Get alerts so you never miss free money.
No spam. Unsubscribe anytime. We respect your privacy.